l glutathione and sjogren's syndrome The role of S-transferases in human disease pathogenesis their current inhibitors Metabolic impact of low dose
Metabolic impact of low dose IL 2 therapy for primary Sjgren's Syndrome in a double blind, randomized clinical trial Clinical Rheumatology Springer Nature Link What Causes Sjgren's Syndrome Pompa Program Sjgren's disease metabolome reveals biomarker signatures to characterise patients and assess disease activity RMD Open Mechanism of Luteolin in the Treatment of Primary Sjogren's Syndrome: a Study Based on Systems Biology and Cell Experiments ACS Omega
Pay in 4 interest-free payments of $7.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



